BioTrackTHC vs Phenom
Side-by-side comparison of AI visibility scores, market position, and capabilities
Cannabis seed-to-sale tracking and compliance software used by state regulators and licensed operators to monitor inventory through the full supply chain. Fort Lauderdale, FL.
About
BioTrackTHC is a Fort Lauderdale, Florida-based cannabis technology company specializing in seed-to-sale tracking and compliance software for both government regulators and licensed cannabis operators. The company is notable for having been selected by multiple state cannabis regulatory agencies to build and operate the official state traceability systems used to track cannabis from cultivation through processing, distribution, and retail sale. This regulatory-side business distinguishes BioTrackTHC from vendors that serve only licensed businesses.\n\nOn the operator side, BioTrackTHC provides dispensary and cultivator software that integrates directly with state-mandated tracking systems, simplifying compliance reporting for licensed cannabis businesses. Because the company built and operates several state systems, its operator software products benefit from deep familiarity with the technical requirements and data exchange protocols of government traceability infrastructure. This regulatory expertise is a meaningful competitive advantage when selling to operators who prioritize compliance reliability above other software features.\n\nBioTrackTHC has been acquired by Forian Inc. (FORA), becoming part of a broader data and analytics holding company. The cannabis industry's regulatory environment continues to evolve as more states legalize adult-use cannabis, creating ongoing demand for compliant tracking solutions. BioTrackTHC has operated state systems in Washington, New Mexico, Hawaii, Illinois, and several other jurisdictions, giving it a unique vantage point on regulatory requirements that informs its commercial software products.
AI talent experience unicorn valued at $1.3B; raised $169M total including $100M Series D led by B Capital; 1,200+ employees; Deloitte Fast 500 honoree
About
Phenom is an AI talent experience platform that transforms how large enterprises attract, engage, develop, and retain employees across the full talent lifecycle. Founded to replace the fragmented point solutions in HR technology — separate tools for recruiting, career sites, internal mobility, and employee development — Phenom built a unified platform using AI to personalize the talent experience for every stakeholder: candidates, employees, recruiters, and managers. The company's mission is to help a billion people find the right work and give employers the AI infrastructure to build great teams.\n\nPhenom's platform spans candidate experience (AI-powered career sites, chatbots, and interview scheduling), recruiter productivity (AI sourcing, screening, and CRM), employee development (internal mobility recommendations and career pathing), and manager insights (team analytics and retention risk signals). With 1,200 or more employees and deep integrations with major HRIS and ATS platforms, Phenom serves enterprise customers in manufacturing, healthcare, retail, and financial services. The company was recognized in Deloitte's Fast 500, reflecting its consistent revenue growth trajectory.\n\nPhenom has raised $169 million in total funding, including a $100 million Series D led by B Capital Group, and achieved a $1.3 billion valuation — cementing its status as the leading independent AI talent platform unicorn. It competes with Workday, SAP SuccessFactors, and point solutions like Greenhouse and Beamery, differentiating through the breadth of its unified platform and the depth of its AI personalization layer. In an enterprise HR market undergoing rapid AI transformation, Phenom's platform consolidation thesis is resonating with CHROs looking to reduce vendor sprawl.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.